Prostate cancer: open trials in Portugal

9 open trials have a site in Portugal. Registry data; only the trial team decides who can take part.

NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Hospital da Luz Lisboa, Lisbon · Hospital De Santa Maria, Lisbon · Unidade Local de Saúde (ULS) Loures Odivelas, Loures · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. (IPO Porto), Porto
Registry updated 2026-10-30
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
CCAB Centro Clinico Academico Braga Associacao, Braga · Galo Saude Parcerias Cascais S.A., Cascais · Hospital Cuf Tejo S.A., Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Unidade Local De Saude De Santo Antonio E.P.E., Porto · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia
Registry updated 2026-10-20
NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen
Unidade Local de Saude de Santa Maria EPE - Hospital de Santa Maria, Lisbon · Hospital da Luz, SA, Lisbon · Unidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao, Porto · Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto · Unidade Local de Saude de Gaia-Espinho, EPE, Vila Nova de Gaia
Registry updated 2026-10-20
NCT07344779
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-19
2025-520555-89-00
Phase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Trial Treatment · Phase 3 · Amgen Inc.
Hospital da Luz, S.A, Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto · Unidade Local de Saude de Sao Joao E.P.E., Porto · Unidade Local de Saúde de Gaia/Espinho, E. P. E, Vila Nova de Gaia
Registry updated 2026-09-17
NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 1 · Amgen
START Lisbon, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte E.P.E., Lisbon · Hospital da Luz, S.A, Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-08-21
NCT07754929
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer Survivors
Trial Treatment · Universidade do Porto
Faculdade de Psicologia e de Ciências da Educação da Universidade do Porto, Porto
Registry updated 2026-08-10
NCT07333066
Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.
Trial Treatment · Phase 3 · Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
CCAB Centro Clinico Academico Braga Associacao, Braga · Unidade Local De Saude Do Alto Ave E.P.E., Guimaraes
Registry updated 2026-06-17
NCT04035642
Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)
Trial Treatment · Fundacao Champalimaud
Champalimaud Foundation, Lisbon
Registry updated 2026-05-08

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error